INTEGER HOLDINGS CORP (ITGR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ITGR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ITGR | Former President and Chief Executive Officer, Ebb Therapeutics; Director | 72 | ["retired President and Chief Executive Officer of Ebb Therapeutics","Chairman and Chief Executive Officer of Lake Region Medical","senior executive roles at Philips Respironics","hospital leadership positions at GKN Sinter Metals and BOC Group plc","director of Linguaflex, Inc.","previously served on the boards of Eargo, Inc. and Vapotherm, Inc.","significant executive leadership and medical device industry experience","background in strategic transactions, public company governance, and organizational leadership"] | ["Compensation & Organization (Chair)","Audit","Technology Strategy","Compensation and Organization","Corporate Governance and Nominating"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Spence retired in August 2019 as President and Chief Executive Officer of Ebb Therapeutics, a medical products company focused on the treatment of insomnia, a role he held since 2017. Previously, he served as Chairman and Chief Executive Officer of Lake Region Medical until its acquisition in 2015 by the Company and held senior executive roles at Philips Respironics and Philips Home Healthcare Solutions. Earlier in his career, Mr. Spence held leadership positions at GKN Sinter Metals and BOC Group plc. He currently serves as a director of Linguaflex, Inc., a privately-held medtech company and previously served on the boards of Eargo, Inc. and Vapotherm, Inc. Mr. Spence brings significant executive leadership and medical device industry experience, including serving as chief executive of multiple healthcare companies. His background in strategic transactions, public company governance, and organizational leadership and his deep industry experience supports the Board s oversight of long-term/growth strategy, management succession, and long term value creation. Age: 71 Director Since: 2016 Integer Committees: Compensation and Organization (Chair) Corporate Governance and Nominating Technology Strategy